Parkside Investments’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,663
Closed -$959K 95
2024
Q1
$959K Sell
17,663
-35,255
-67% -$1.84M 0.15% 65
2023
Q4
$2.98M Sell
52,918
-23,900
-31% -$1.35M 0.5% 51
2023
Q3
$4.74M Sell
76,818
-1,782
-2% -$113K 0.87% 48
2023
Q2
$4.64M Buy
78,600
+3,600
+5% +$229K 0.87% 49
2023
Q1
$5.54M Buy
75,000
+58,500
+355% +$4.51M 1.04% 44
2022
Q4
$1.2M Buy
16,500
+5,000
+43% +$395K 0.24% 60
2022
Q3
$958K Buy
+11,500
New +$989K 0.21% 62

Other funds holding NTR

Parkside Investments's NTR Position: Q2 2024 in Review

Parkside Investments sold out of Nutrien (NTR) in Q2 2024, closing a stake of 17,663 shares — an estimated $959K sold.

Parkside Investments first reported a position in NTR in Q3 2022 and held it in 7 quarters. The position peaked at $5.54M in Q1 2023. 629 funds tracked by Wall St. Rank hold NTR as of Q2 2024.

  • Parkside Investments reported no remaining Nutrien position as of Q2 2024 after selling out during the quarter.
  • Parkside Investments sold 17,663 Nutrien shares in Q2 2024, an estimated $959K.
  • Parkside Investments first reported a position in Nutrien in Q3 2022 and held it in 7 quarters.
  • Parkside Investments's Nutrien position peaked at $5.54M in Q1 2023.
  • 629 funds tracked by Wall St. Rank held Nutrien as of Q2 2024.

Based on Parkside Investments's 13F filing for Q2 2024, filed 11 Jul 2024.